374 related articles for article (PubMed ID: 22074408)
21. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems.
Ma W; Chabot JG; Powell KJ; Jhamandas K; Dickerson IM; Quirion R
Neuroscience; 2003; 120(3):677-94. PubMed ID: 12895509
[TBL] [Abstract][Full Text] [Related]
22. Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons.
Cornelison LE; Hawkins JL; Durham PL
Neuroscience; 2016 Dec; 339():491-501. PubMed ID: 27746346
[TBL] [Abstract][Full Text] [Related]
23. Expression and function of calcitonin gene-related peptide (CGRP) receptors in trigeminal ganglia of R192Q Cacna1a knock-in mice.
Vilotti S; Vana N; Van den Maagdenberg AM; Nistri A
Neurosci Lett; 2016 May; 620():104-10. PubMed ID: 27021026
[TBL] [Abstract][Full Text] [Related]
24. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion.
Zhang Z; Winborn CS; Marquez de Prado B; Russo AF
J Neurosci; 2007 Mar; 27(10):2693-703. PubMed ID: 17344407
[TBL] [Abstract][Full Text] [Related]
25. Distribution of CGRP and CGRP receptor components in the rat brain.
Warfvinge K; Edvinsson L
Cephalalgia; 2019 Mar; 39(3):342-353. PubMed ID: 28856910
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
27. Calcitonin receptor-like receptor and receptor activity modifying protein 1 in the rat dorsal horn: localization in glutamatergic presynaptic terminals containing opioids and adrenergic alpha2C receptors.
Marvizón JC; Pérez OA; Song B; Chen W; Bunnett NW; Grady EF; Todd AJ
Neuroscience; 2007 Aug; 148(1):250-65. PubMed ID: 17614212
[TBL] [Abstract][Full Text] [Related]
28. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat.
Cottrell GS; Roosterman D; Marvizon JC; Song B; Wick E; Pikios S; Wong H; Berthelier C; Tang Y; Sternini C; Bunnett NW; Grady EF
J Comp Neurol; 2005 Sep; 490(3):239-55. PubMed ID: 16082677
[TBL] [Abstract][Full Text] [Related]
29. Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment.
Seiler K; Nusser JI; Lennerz JK; Neuhuber WL; Messlinger K
J Headache Pain; 2013 Sep; 14(1):74. PubMed ID: 24004534
[TBL] [Abstract][Full Text] [Related]
30. mRNA distribution of CGRP and its receptor components in the trigeminovascular system and other pain related structures in rat brain, and effect of intracerebroventricular administration of CGRP on Fos expression in the TNC.
Bhatt DK; Gupta S; Ploug KB; Jansen-Olesen I; Olesen J
Neurosci Lett; 2014 Jan; 559():99-104. PubMed ID: 24321404
[TBL] [Abstract][Full Text] [Related]
31. Central projection of calcitonin gene-related peptide (CGRP)- and substance P (SP)-immunoreactive trigeminal primary neurons in the rat.
Sugimoto T; Fujiyoshi Y; Xiao C; He YF; Ichikawa H
J Comp Neurol; 1997 Feb; 378(3):425-42. PubMed ID: 9034901
[TBL] [Abstract][Full Text] [Related]
32. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
Sheykhzade M; Amandi N; Pla MV; Abdolalizadeh B; Sams A; Warfvinge K; Edvinsson L; Pickering DS
Vascul Pharmacol; 2017 Mar; 90():36-43. PubMed ID: 28192258
[TBL] [Abstract][Full Text] [Related]
33. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
34. Effect of a calcitonin gene-related peptide-binding L-RNA aptamer on neuronal activity in the rat spinal trigeminal nucleus.
Fischer MJM; Schmidt J; Koulchitsky S; Klussmann S; Vater A; Messlinger K
J Headache Pain; 2018 Jan; 19(1):3. PubMed ID: 29335794
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Messlinger K; Fischer MJ; Lennerz JK
Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
[TBL] [Abstract][Full Text] [Related]
36. The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats.
Vogler B; Kuhn A; Mackenzie KD; Stratton J; Dux M; Messlinger K
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686275
[TBL] [Abstract][Full Text] [Related]
37. Selective deafferentation of convergent inputs to trigeminal subnucleus caudalis: effects on calcitonin gene-related peptide distribution.
Stover JD; Schwab CA; Matthews MA
Somatosens Mot Res; 1992; 9(2):107-30. PubMed ID: 1502861
[TBL] [Abstract][Full Text] [Related]
38. Role of calcitonin gene-related peptide in pain regulation in the parabrachial nucleus of naive rats and rats with neuropathic pain.
Wang LL; Wang HB; Fu FH; Yu LC
Toxicol Appl Pharmacol; 2021 Mar; 414():115428. PubMed ID: 33524449
[TBL] [Abstract][Full Text] [Related]
39. The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system.
Messlinger K
J Headache Pain; 2018 Mar; 19(1):22. PubMed ID: 29532195
[TBL] [Abstract][Full Text] [Related]
40. Glyceroltrinitrate facilitates stimulated CGRP release but not gene expression of CGRP or its receptor components in rat trigeminal ganglia.
Eberhardt M; Neeb L; Vogel EM; Tiegs G; Reuter U; Messlinger K; Fischer MJ
Neuropeptides; 2009 Dec; 43(6):483-9. PubMed ID: 19864020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
